These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38067335)
1. Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung. Izaki Y; Amatya VJ; Kambara T; Kushitani K; Miyata Y; Okada M; Takeshima Y Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067335 [TBL] [Abstract][Full Text] [Related]
2. Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma. Baykara Y; Xiao Y; Yang D; Yakirevich E; Maleki S; Garcia-Moliner M; Wang LJ; Huang CK; Lu S Virchows Arch; 2022 Jul; 481(1):31-39. PubMed ID: 35357570 [TBL] [Abstract][Full Text] [Related]
3. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56. Chen JF; Yang C; Sun Y; Cao D Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384 [TBL] [Abstract][Full Text] [Related]
4. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors. Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493 [TBL] [Abstract][Full Text] [Related]
5. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review. Zou Q; Zhang L; Cheng Z; Guo X; Cao D Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139 [TBL] [Abstract][Full Text] [Related]
6. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56. Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626 [TBL] [Abstract][Full Text] [Related]
7. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens. Doxtader EE; Mukhopadhyay S Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191 [TBL] [Abstract][Full Text] [Related]
8. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma. Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383 [TBL] [Abstract][Full Text] [Related]
9. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584 [TBL] [Abstract][Full Text] [Related]
10. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections. Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579 [TBL] [Abstract][Full Text] [Related]
11. High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin. Litmeyer AS; Konukiewitz B; Kasajima A; Foersch S; Schicktanz F; Schmitt M; Kellers F; Grass A; Jank P; Lehman B; Gress TM; Rinke A; Bartsch DK; Denkert C; Weichert W; Klöppel G; Jesinghaus M J Pathol Clin Res; 2023 Nov; 9(6):498-509. PubMed ID: 37608427 [TBL] [Abstract][Full Text] [Related]
12. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears. Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851 [TBL] [Abstract][Full Text] [Related]
13. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas. Ting CH; Wang TY; Wu PS Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849 [TBL] [Abstract][Full Text] [Related]
14. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens. Viswanathan K; Siddiqui MT; Borczuk AC J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782 [TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Markers Insulinoma-Associated Protein 1, Chromogranin, Synaptophysin, and CD56 Show Rare Positivity in Adenocarcinoma Ex-Goblet Cell Carcinoids. Yang C; Gonzalez I; Zhang L; Cao D Gastroenterology Res; 2019 Jun; 12(3):120-127. PubMed ID: 31236152 [TBL] [Abstract][Full Text] [Related]
16. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56. Kriegsmann K; Zgorzelski C; Kazdal D; Cremer M; Muley T; Winter H; Longuespée R; Kriegsmann J; Warth A; Kriegsmann M Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):237-242. PubMed ID: 30358615 [TBL] [Abstract][Full Text] [Related]
17. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer. Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906 [TBL] [Abstract][Full Text] [Related]
18. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?]. Schnabel PA; Junker K Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813 [TBL] [Abstract][Full Text] [Related]
19. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity. Rooper LM; Sharma R; Li QK; Illei PB; Westra WH Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469 [TBL] [Abstract][Full Text] [Related]
20. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract. Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]